Covaxin manufacturing may get a booster shot as demand for vaccines grows - Business Standard

Bharat Biotech also has another site at Bengaluru that is currently making vaccines other than Covaxin

Topics
Coronavirus Vaccine | Manufacturing growth | Indian pharma companies

Sohini Das  |  Mumbai 

Last Updated at March 25, 2021 06:10 IST

As demand for vaccines grows with states pressing the pedal to increase vaccinations per day, the manufacturing of indigenous vaccine Covaxin may get a boost. Hyderabad-based vaccine major Bharat Biotech, which is now making 40 million doses of the vaccine per month, has an option to activate another two sites if the need arises — one at Ankleshwar in Gujarat and another at Bengaluru.

Both are company-owned sites, a company spokesperson infor­m­ed without divulging further details. The Mahar­ashtra government too has indicated that 126 million doses of Covaxin can be ...

Key stories on business-standard.com are available to premium subscribers only.

Already a premium subscriber? LOGIN NOW

MONTHLY STAR

Business Standard Digital

Business Standard Digital Monthly Subscription

149.00  

subscribe

Complete access to the premium product

Convenient - Pay as you go

Pay using Master/Visa Credit Card & ICICI VISA Debit Card

Auto renewed (subject to your card issuer's permission)

Cancel any time in the future

Choose Payment Method

Note: Subscription will be auto renewed, you may cancel any time in the future without any questions asked.

Total Amount

Rs. 149.00

Requires personal information

What you get?

ON BUSINESS STANDARD DIGITAL

• Unlimited access to all the content on any device through browser or app.
• Exclusive content, features, opinions and comment – hand-picked by our editors, just for you.
• Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
• Track the industry of your choice with a daily newsletter specific to that industry.
• Stay on top of your investments. Track stock prices in your portfolio.
• 18 years of archival data.

NOTE :

• The product is a monthly auto renewal product.
• Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
• To cancel, communicate from your registered email id and send the email with the cancellation request to assist@bsmail.in. Include your contact number for speedy action. Requests mailed to any other ID will not be acknowledged or actioned upon.

SMART ANNUAL

Business Standard Digital

Business Standard Digital - 12 Months

1499.00

subscribe

Get 12 months of Business Standard digital access

Single Seamless Sign-up to Business Standard Digital

Convenient - Once a year payment

Pay using an instrument of your choice - Credit/Debit Cards, Net Banking, Payment Wallets accepted

Exclusive Invite to select Business Standard events

Choose Payment Method

Note: Subscription will be auto renewed, you may cancel any time in the future without any questions asked.

Total Amount

Rs. 1499.00

What you get

ON BUSINESS STANDARD DIGITAL

• Unlimited access to all content on any device through browser or app.
• Exclusive content, features, opinions and comment - hand-picked by our editors, just for you.
• Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
• Track the industry of your choice with a daily newsletter specific to that industry.
• Stay on top of your investments. Track stock prices in your portfolio.

NOTE :

• This product is a monthly auto renewal product.
• Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
• To cancel, communicate from your registered email id and send the mail with the request to assist@bsmail.in. Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, March 25 2021. 06:10 IST

The Link Lonk


March 25, 2021 at 07:40AM
https://ift.tt/3lVw5bR

Covaxin manufacturing may get a booster shot as demand for vaccines grows - Business Standard

https://ift.tt/2DVP6sH